Wells Peter G, McCallum Gordon P, Lam Kyla C H, Henderson Jeffrey T, Ondovcik Stephanie L
Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.
Birth Defects Res C Embryo Today. 2010 Jun;90(2):103-9. doi: 10.1002/bdrc.20177.
Several teratogenic agents, including ionizing radiation and xenobiotics such as phenytoin, benzo[a]pyrene, thalidomide, and methamphetamine, can initiate the formation of reactive oxygen species (ROS) that oxidatively damage cellular macromolecules including DNA. Oxidative DNA damage, and particularly the most prevalent 8-oxoguanine lesion, may adversely affect development, likely via alterations in gene transcription rather than via a mutational mechanism. Contributions from oxidative DNA damage do not exclude roles for alternative mechanisms of initiation like receptor-mediated processes or the formation of covalent xenobiotic-macromolecular adducts, damage to other macromolecular targets like proteins and lipids, and other effects of ROS like altered signal transduction. Even in the absence of teratogen exposure, endogenous developmental oxidative stress can have embryopathic consequences in the absence of key pathways for detoxifying ROS or repairing DNA damage. Critical proteins in pathways for DNA damage detection/repair signaling, like p53 and ataxia telangiectasia mutated, and DNA repair itself, like oxoguanine glycosylase 1 and Cockayne syndrome B, can often, but not always, protect the embryo from ROS-initiating teratogens. Protection may be variably dependent upon such factors as the nature of the teratogen and its concentration within the embryo, the stage of development, the species, strain, gender, target tissue and cell type, among other factors.
包括电离辐射和苯妥英、苯并[a]芘、沙利度胺及甲基苯丙胺等外源性物质在内的多种致畸剂,可引发活性氧(ROS)的形成,这些活性氧会对包括DNA在内的细胞大分子造成氧化损伤。氧化性DNA损伤,尤其是最常见的8-氧代鸟嘌呤损伤,可能会对发育产生不利影响,可能是通过基因转录的改变而非突变机制。氧化性DNA损伤的作用并不排除受体介导过程等其他起始机制、共价外源性物质-大分子加合物的形成、对蛋白质和脂质等其他大分子靶点的损伤以及ROS的其他效应(如信号转导改变)所起的作用。即使在没有致畸剂暴露的情况下,内源性发育性氧化应激在缺乏清除ROS或修复DNA损伤的关键途径时也可能产生胚胎病变后果。DNA损伤检测/修复信号通路中的关键蛋白,如p53和共济失调毛细血管扩张症突变蛋白,以及DNA修复本身,如氧代鸟嘌呤糖基化酶1和科凯恩综合征B蛋白,通常但并非总是能保护胚胎免受ROS引发的致畸剂的影响。这种保护可能会因致畸剂的性质及其在胚胎内的浓度、发育阶段、物种、品系、性别、靶组织和细胞类型等因素而有所不同。